NCTN Catalog

The information presented here is estimated and for informational purposes only. Please consult the specific biospecimen resource for more detailed and precise inventory data.

You searched for:

  • Organ Site/Path DX: Head & Neck

Found 20 results.

NCTN Groups & AccessOrgan Site/Path DXProtocol Number & TitleTotal Patient AccrualSpecimen Types
ALLIANCEHead & NeckZ0360: A Trial of Lymphatic Mapping and Sentinel Node Lymphadenectomy for Patients with T1 or T2 Clinically N0 Oral Cavity Squamous Cell Carcinoma Buffy Coat (134), DNA (19), Fixed Tissue Block (26), Fixed Tissue Slide (123), Frozen Tissue (73), Plasma (2), RNA (26), Serum (143)
COG via NavigatorHead & NeckARAR0331: Treatment of Childhood Nasopharyngeal Carcinoma with Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy111Buffy Coat (48), Fixed Tissue Block (7), Frozen Tissue (21), Plasma (73), Serum (24)
COGHead & NeckARAR0331 : Treatment of Childhood Nasopharyngeal Carcinoma with Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy111Buffy Coat (2), Fixed Tissue (2), Frozen Tissue (1), Plasma (1), Serum (2)
ECOG-ACRIN via NavigatorHead & NeckE1302: Phase III Randomized, Placebo Controlled, Trial of Docetaxel Versus Docetaxel Plus ZD1839 (Iressa, Gefitinib) in Performance Status 2 or Previously Treated Patients with Recurrent or Metastatic Head and Neck Cancer270Fixed Tissue Block (83), Fixed Tissue Slide (132), Plasma (2), Serum (1), Whole Blood (101)
ECOG-ACRIN via NavigatorHead & NeckE1305: A Phase III Randomized Trial of Chemotherapy with or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer403Cells (160), Fixed Tissue Block (135), Fixed Tissue Slide (68), Plasma (248), Serum (218), Whole Blood (49)
ECOG-ACRIN via NavigatorHead & NeckE1395: A Randomized Phase III Evaluation of Paclitaxel + Cisplatin Versus Cisplatin + 5-FU in Advanced Head and Neck Cancer218Fixed Tissue Block (38), Fixed Tissue Slide (10)
ECOG-ACRIN via NavigatorHead & NeckE3311: Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer.519Cells (104), Fixed Tissue Block (396), Plasma (102), Saliva (1), Serum (42)
ECOG-ACRIN via NavigatorHead & NeckE5397: Randomized, Double Blind, Placebo Controlled Phase III Evaluation of Cisplatin + Placebo Versus Cisplatin + C225 a Mouse/Human Monoclonal Antibody to the Epidermal Growth Factor Receptor, in Patients with Metastatic and/or Recurrent Squamous Cell Cancer of the Head and Neck123Fixed Tissue Block (26), Fixed Tissue Slide (66)
NRGHead & NeckRTOG 0129: A Phase III Trial of Concurrent Radiation and Chemotherapy (Followed by Surgery for Residual Primary/N2-3 Nodal Disease) for Advanced Head and Neck Carcinomas743Fixed Tissue Block (220), Fixed Tissue Slide (635), Plasma (1), Serum (4), Whole Blood (235)
NRG via NavigatorHead & NeckRTOG 0421: A Phase III Trial for Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Re-Irradiation and Chemotherapy versus Chemotherapy Alone15Buffy Coat (6), Plasma (7), Serum (7)
NRGHead & NeckRTOG 0514: Establishment of a Head and Neck Cancer Tissue/Specimen Repository351Buffy Coat (163), Fixed Tissue Block (225), Fixed Tissue Slide (230), Frozen Tissue (57), Plasma (168), Saliva (137), Serum (168)
NRGHead & NeckRTOG 0522: A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab C225 [Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas942Buffy Coat (277), Fixed Tissue Block (388), Fixed Tissue Slide (631), Plasma (504), Serum (504), Whole Blood (33)
NRGHead & NeckRTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer627Buffy Coat (16), Fixed Tissue Block (655), Fixed Tissue Slide (670), Plasma (435), Serum (429), Whole Blood (420)
NRGHead & NeckRTOG 9003: Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck1,113Fixed Tissue Block (576), Fixed Tissue Slide (838)
NRGHead & NeckRTOG-1008: A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors252Buffy Coat (2), Fixed Tissue Block (166), Fixed Tissue Slide (233), Plasma (177), Serum (177), Whole Blood (167)
NRGHead & NeckRTOG-95-01: Phase III intergroup trial of surgery followed by (1) radiotherapy vs. (2) radiochemotherapy for resectable high risk Squamous Cell Carcinoma of the Head and Neck459Fixed Tissue Block (196), Fixed Tissue Slide (431)
NRGHead & NeckRTOG-95-12: A Randomized Study of Hyperfractionation Versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord250Fixed Tissue Block (109), Fixed Tissue Slide (236)
NRGHead & NeckRTOG-99-03: A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated with Radiotherapy for Carcinoma of the Head and Neck148Fixed Tissue Block (39), Fixed Tissue Slide (99)
SWOGHead & NeckS0427: A Phase III Trial of Standard Fractionation Radiation and Concurrent Single Agent Cisplatin, with and without Docetaxel, Cisplatin, and 5-Fluorouracil Induction Chemotherapy, in Patients with Advanced Oropharyngeal Squamous Cell Cancer6Fixed Tissue Block (4), Fixed Tissue Slide (2), Plasma (1), Serum (5)
SWOGHead & NeckS0431: Phase II Study of Trastuzumab (NSC-688097) in Advanced High Grade Salivary Gland Carcinoma3Fixed Tissue Block (1), Fixed Tissue Slide (2)